newsfilter.io

Richard Isaacson

Showing 1–3 of 3 transcripts.

  1. Milken Institute59 min

    Breakthroughs Reshaping Aging and Longevity | Global Conference 2026

    Richard Lui, Joe Betts-LaCroix, Tom Hale, Richard Isaacson, Carina Kern, John Whyte

    Leaders from Retro Biosciences, Aura Health, Link Jevity, and the AMA convened to discuss accelerating longevity medicine through therapies targeting necrosis and autophagy alongside continuous health monitoring. The panel identified critical systemic barriers including outdated reimbursement models and fragmented disease silos while highlighting breakthroughs like generative AI-driven drug discovery and home-based neuro-insight testing. With a predicted market readiness of 3 to 6 out of 10, the group anticipates the first anti-aging therapeutics will reach consumers within five years as the industry shifts from reactive sick care to proactive aging reversal.

  2. Milken Institute56 min

    Innovating Hope: Charting the New Era of Alzheimer's & Other Dementias | Future of Health Summit

    Allison Aubrey, Kris Engskov, Jessie Fahrbach, Howard Fillit, Richard Isaacson, Joanne Pike, Chris Inskov

    Recent FDA approvals of amyloid-targeting drugs and advanced biomarkers have established the foundation for a new era of disease-modifying treatments, prompting a strategic industry shift toward preclinical intervention and combination therapies targeting multiple pathological pathways. Concurrently, integrated care models like the GUIDE initiative are reducing hospitalizations while AI-driven diagnostics and lifestyle-based prevention strategies aim to address the critical shortage of providers for the estimated 47 million Americans with silent Alzheimer's pathology. With significant government funding increases and projected 2030 innovations in low-cost at-home monitoring, the field is rapidly evolving toward a precision prevention framework that combines pharmacological, metabolic, and digital interventions to delay cognitive decline.

  3. Milken Institute59 min

    The Roadmap to Longevity | Global Conference 2025

    Gadi Schwartz, Dan Buettner, Laura Deming, Richard Isaacson, Eric Verdin, Vonda Wright

    Panels including Dan Buettner, Laura Deming, and Dr. Eric Verdin emphasized a paradigm shift from extending mere life span to maximizing health and brain span through lifestyle interventions that determine 93% of longevity outcomes. While no single "hack" exists, experts project that combining optimized nutrition, walkable urban design, and emerging precision medicine could push healthy life expectancy to 90–95 years, with the first FDA-approved longevity drug anticipated within the next five years. Despite this potential for breakthrough therapies, the consensus highlights a critical funding crisis threatening US biomedical research and calls for systemic reforms to democratize access to preventive care rather than reactive sick care.